Literature DB >> 10478561

Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats.

S Hashimoto1, T Inoue, T Koyama.   

Abstract

In an attempt to clarify the role of the brain serotonergic system in the psychopathology of anxiety, we examined the effect of a psychological stress, conditioned fear stress, on extracellular serotonin (5-hydroxytryptamine, 5-HT) concentrations in the rat medial prefrontal cortex using the method of in vivo microdialysis, while simultaneously observing conditioned fear stress-induced freezing behavior, an index of anxiety. Conditioned fear stress increased extracellular 5-HT levels in the medial prefrontal cortex, and this 5-HT level increase was followed by a resolution of the freezing behavior. A dose of 10 mg/kg of a selective 5-HT reuptake inhibitor, citalopram, administered 60 min before exposure to conditioned fear stress increased extracellular 5-HT concentrations immediately and potently, reducing freezing behavior. These findings strongly suggest that facilitation of brain 5-HT neurotransmission decreases anxiety, which is in agreement with the clinical reports that selective 5-HT reuptake inhibitors are effective in the treatment of anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478561     DOI: 10.1016/s0014-2999(99)00441-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  24 in total

Review 1.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

2.  The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.

Authors:  Liliana P Montezinho; Silke Miller; Niels Plath; Nanna Hovelsø Jensen; Jens-Jakob Karlsson; Louise Witten; Arne Mørk
Journal:  Psychopharmacology (Berl)       Date:  2010-07-30       Impact factor: 4.530

3.  Behavioral impairments and serotonin reductions in rats after chronic L-dopa.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2015-06-03       Impact factor: 4.530

4.  Tryptophan depletion decreases the recognition of fear in female volunteers.

Authors:  C J Harmer; R D Rogers; E Tunbridge; P J Cowen; G M Goodwin
Journal:  Psychopharmacology (Berl)       Date:  2003-04-04       Impact factor: 4.530

Review 5.  Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders.

Authors:  Toshiharu Shimazaki; Takao Yoshimizu; Shigeyuki Chaki
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Effect of paroxetine on enhanced contextual fear induced by single prolonged stress in rats.

Authors:  Terumichi Takahashi; Shigeru Morinobu; Yasuyuki Iwamoto; Shigeto Yamawaki
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

7.  Genetic associations with performance on a behavioral measure of distress intolerance.

Authors:  Ananda B Amstadter; Stacey B Daughters; Laura Macpherson; Elizabeth K Reynolds; Carla Kmett Danielson; Frances Wang; Marc N Potenza; Joel Gelernter; C W Lejuez
Journal:  J Psychiatr Res       Date:  2011-10-22       Impact factor: 4.791

8.  Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.

Authors:  Madhurima Benekareddy; Nathalie M Goodfellow; Evelyn K Lambe; Vidita A Vaidya
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

9.  Chlorpheniramine exerts anxiolytic-like effects and activates prefrontal 5-HT systems in mice.

Authors:  Shigeo Miyata; Shoko Hirano; Masahiro Ohsawa; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

10.  Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.

Authors:  Branden J Stansley; Bryan K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  2014-09-11       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.